Found 9 matching trials
ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE)
N/APatients with Critical COVID-19 and respiratory failure who are ineligible ...
Status
No Longer Available
Location
Dignity Health-Mercy Gilbert Medical Center
Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)
PHASE3This study looks at the safety and effectiveness of Aviptadil in treating C...
Location
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
PHASE2The goal of this project is to rapidly screen promising agents, in the sett...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS
PHASE2The world is currently experiencing a coronavirus (CoV-2) pandemic. A new (...
Location
Cantonal Hospital Baselland Liestal
A Clinical Study Evaluating Inhaled Aviptadil on COVID-19
PHASE2This study is a multicenter, prospective, placebo-controlled, comparative, ...
Location
Başkent University School of Medicine
Inhaled ZYESAMI (Aviptadil Acetate) for Treatment of Severe COVID-19
PHASE3Brief Summary:
SARS-CoV-2 virus infection is known to cause Lung Injury th...
Location
Multiple Locations
Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19
PHASE2Brief Summary:
SARS-CoV-2 virus infection is known to cause Lung Injury th...
Location
St. Jude Medical Center
Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure
PHASE2Novel Corona Virus (SARS-CoV-2) is known to cause Respiratory Failure, whic...
Location
St. Jude Medical Center
ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
PHASE3This study looks at the safety and effectiveness of different drugs in trea...
Location
Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue